Shire Recruiting 80-90 Fosrenol Reps; Adderall XR Adult User Fee Is Mid-Year
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Shire is recruiting 80 to 90 Fosrenol sales reps in anticipation of a second-half 2004 launch of the non-calcium phosphate binder for treatment of end-stage renal disease, the firm said April 29.